The vascular stabilizing effects of ANG2 inhibition on delaying tumor progression and stimulating antitumor immunity make ANG2 an ideal target for combination treatment with other targeted therapies, especially those that induce resistance. The gene discussed is ANGPT2; the disease is neoplasm.